BioPharma Dive Jan 26, 2026 China’s edge in early-stage drugmaking ‘likely to persist,’ Pitchbook says
Roche Media Jan 26, 2026 Roche's Gazyva gets Health Canada approval for lupus nephritis - marketscreener.com
BioPharma Dive Jan 26, 2026 Sarepta, battling slowing sales, claims Duchenne gene therapy’s impact grows with time
Endpoints News Jan 26, 2026 Genyro licences DNA builder from Caltech; Dizal targets Hong Kong listing